Siste måned
30 dager
0
NETTO POSISJON (NOK)
Handler
5
Kjøp
0
Salg
0
6 måneder
180 dager
0
NETTO POSISJON (NOK)
Handler
5
Kjøp
0
Salg
0
Historikk
ℹ️ Om innsidehandel
Primærinnsidere er personer med ledelsesansvar og deres nærstående. Meldeplikt inntrer når transaksjoner når EUR 5 000 i et kalenderår.
Meldefrist: umiddelbart, senest tre virkedager. Handelsforbud 30 dager før pliktig finansiell rapportering.
Transaksjoner
Mer info 👉
| Dato | Innsider | Antall | Pris | Verdi |
|---|---|---|---|---|
| 28.08.2026 |
Edminson John Morten
CFO
|
130 000 | - | - |
| 28.08.2026 |
PER EDVARD WALDAY
CEO
|
250 000 | - | - |
| 28.08.2026 |
Amir Moshe Snapir
CMO
|
100 000 | - | - |
| 28.08.2026 |
Johan Caspar Foghsgaard
CBO
|
200 000 | - | - |
| 28.08.2026 |
Svein Kvåle
COO
|
100 000 | - | - |
| 05.02.2026 |
Leiv Askvig
Board member
via Sundt AS
|
420 396 | 1.23 | 517 087 |
| 05.02.2026 |
Ann-Tove Kongsnes
Board member
via Investinor Direkte AS
|
4 875 920 | 1.23 | 5 997 382 |
| 05.02.2026 |
Leiv Askvig
Board member
via HelenelSundt AS
|
2 050 577 | 1.23 | 2 522 210 |
| 05.02.2026 |
Leiv Askvig
Board member
via Basen Kapital AS
|
87 107 | 1.23 | 107 142 |
| 05.02.2026 |
Anders Wold
Chairperson
|
69 685 | 1.23 | 85 713 |
| 24.11.2025 |
Per Walday
Chief Executive Officer
|
610 643 | - | - |
| 24.11.2025 |
Svein Kvåle
COO
|
60 000 | - | - |
| 24.11.2025 |
Caspar Foghsgaard
SVP Commercial & BD
|
60 000 | - | - |
| 24.11.2025 |
John M. Edminson
Chief Financial Officer
|
60 000 | - | - |
| 24.11.2025 |
Amir Snapir
CMO
|
120 000 | - | - |
| Vis færre ▲ | ||||
Vis alle 15 transaksjoner
▼
Pressemeldinger
| Dato | Melding |
|---|---|
| 31.08.2026 |
EXACT Therapeutics AS – Issuance of share options
OSLO, 31 August 2026: As part of the long-term incentive programme of EXACT Therapeutics AS (“The Company”), a total of 1,300,000 share options have b...
|
| 05.02.2026 |
EXACT Therapeutics: Warrants exercise by leading shareholders and primary insiders
Oslo, Norway, 5 February 2026. Reference is made to the stock exchange announcement by EXACT Therapeutics AS (the "Company", Euronext Growth ticker: E...
|
| 24.11.2025 |
EXACT Therapeutics AS: New option program and receipt of share options by primary insiders
24 November 2025: EXACT Therapeutics AS ("EXACT Tx" or the "Company") announces that the Company as of today has introduced a new long-term incentive ...
|